Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

EBS Emergent Biosolutions Inc

4,49

-0,20 (-4,26%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:57:32

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Donald DeGolyer

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Emergent Biosolutions Charts.

Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Emergent Biosolutions Charts.

News Emergent Biosolutions Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 10 April 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 10 April 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Donnerstag 10 April 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 31 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Emergent BioSolutions Announces Stock Repurchase Program
Montag 31 März 2025 (1 Woche vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 24 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 21 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 21 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Freitag 21 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
Donnerstag 20 März 2025 (3 Wochen vor) • GlobeNewswire Inc.

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Donnerstag 20 März 2025 (3 Wochen vor) • GlobeNewswire Inc.

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Mittwoch 19 März 2025 (3 Wochen vor) • GlobeNewswire Inc.

Weitere Emergent Biosolutions Inc News-Artikel

BNP Paribas (QX)

Euro vs US Dollar

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen